11:13 AM EST - CV Technologies Inc. : maker of the Cold-fX cold and flu treatment, reported Monday a drop in fourth-quarter profit to $506,000 from a year-ago $3.3 million as the company booked higher operating and marketing spending associated with its launch of the remedy into the U.S market. However, quarterly revenue shot up 93 percent. CV Technologies Inc.
shares T.CVQ are trading up 5 cents at $3.24.
